Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9776 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9776 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9704 |
High Similarity |
NPD1549 |
Phase 2 |
0.9291 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.927 |
High Similarity |
NPD2796 |
Approved |
0.9197 |
High Similarity |
NPD1510 |
Phase 2 |
0.9185 |
High Similarity |
NPD1240 |
Approved |
0.9178 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9116 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.911 |
High Similarity |
NPD1934 |
Approved |
0.9051 |
High Similarity |
NPD1607 |
Approved |
0.9041 |
High Similarity |
NPD7411 |
Suspended |
0.9021 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD7075 |
Discontinued |
0.8973 |
High Similarity |
NPD4380 |
Phase 2 |
0.8919 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8867 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8819 |
High Similarity |
NPD6799 |
Approved |
0.8792 |
High Similarity |
NPD7819 |
Suspended |
0.8725 |
High Similarity |
NPD6801 |
Discontinued |
0.869 |
High Similarity |
NPD1511 |
Approved |
0.8667 |
High Similarity |
NPD2801 |
Approved |
0.8645 |
High Similarity |
NPD6166 |
Phase 2 |
0.8645 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8623 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8591 |
High Similarity |
NPD6599 |
Discontinued |
0.8571 |
High Similarity |
NPD1512 |
Approved |
0.8571 |
High Similarity |
NPD6959 |
Discontinued |
0.8553 |
High Similarity |
NPD3882 |
Suspended |
0.8542 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8526 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8483 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8481 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8431 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8428 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8389 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8377 |
Intermediate Similarity |
NPD3749 |
Approved |
0.837 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8345 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8288 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8269 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8261 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8255 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8252 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8214 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.821 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8151 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8138 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8129 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8108 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8102 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8099 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8085 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8082 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8082 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8082 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8074 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8049 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8037 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8026 |
Intermediate Similarity |
NPD920 |
Approved |
0.8025 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8013 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7937 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7914 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7914 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7901 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7862 |
Intermediate Similarity |
NPD943 |
Approved |
0.7847 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7842 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7821 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7808 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7808 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7724 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7687 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7681 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7676 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7669 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.766 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7651 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD919 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3267 |
Approved |
0.761 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7545 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7543 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7535 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7534 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5710 |
Approved |
0.75 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.745 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7436 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7375 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7375 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD411 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7329 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7324 |
Intermediate Similarity |
NPD17 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7267 |
Intermediate Similarity |
NPD8313 |
Approved |
0.726 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7222 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD2403 |
Approved |
0.72 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD1876 |
Approved |
0.719 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7178
|
Intermediate Similarity |
NPD8455 |
Phase 2 |